02097nam a2200433 i 4500001001300000003000600013005001700019007001400036008004100050040002800091042000800119043001200127050002000139074001600159086002600175099002600201110006600227245018200293264006000475300004500535336002600580337002700606338003100633490002200664500011700686533010700803500011700910500003601027500002501063504004101088650005101129650004901180650006401229655003301293776013001326776012901456810005901585999001901644on1027788799OCoLC20180511125019.0he bmb024bbca180307s2017    dcua    bb   f000 0 eng c  aGPObengerdacGPOdMvI  apcc  an-us--- 4aKF25b.E2 2017a  a1000-C (MF)0 aY 4.EC 7:S.HRG.115-70  aY 4.EC 7:S.HRG.115-701 aUnited States.bCongress.bJoint Economic Committee,eauthor.10aEconomic aspects of the opioid crisis :bhearing before the Joint Economic Committee, Congress of the United States, One Hundred Fifteenth Congress, first session, June 8, 2017. 1aWashington :bU.S. Government Publishing Office,c2017.  aiii, 97 pages :billustrations ;c24 cm.  atextbtxt2rdacontent  amicroformbh2rdamedia  amicrofichebhe2rdacarrier1 aS. hrg. ;v115-70  aPaper version available for sale by the Superintendent of Documents, United States Government Publishing Office.  aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2017]e2 microfiches : negative.  aAn error was made on page 1 of S. Hrg. 115-70. House of Representatives should have been United States Congress.  aShipping list no.: 2018-0018-M.  aCRDP Program record.  aIncludes bibliographical references. 0aOpioid abusexEconomic aspectszUnited States. 0aDrug abusexEconomic aspectszUnited States. 0aDrug addictionxTreatmentxEconomic aspectszUnited States. 7aLegislative hearings.2lcgft08iOnline version:aUnited States. Congress. Joint Economic Committee.tEconomic aspects of the opioid crisisw(OCoLC)100496565908iPrint version:aUnited States. Congress. Joint Economic Committee.tEconomic aspects of the opioid crisisw(OCoLC)10048554661 aUnited States.bCongress.bSenate.tS. hrg. ;v115-70.  c271077d271077